Ảnh hưởng của methylphenidate đến sự phát triển não bộ – Cập nhật các thí nghiệm gần đây trên động vật

Rothenberger A, Dopfner M, Sergeant J, Steinhausen HC: ADHD – beyond core symptoms. Not only a European perspective. Eur Child Adolesc Psychiatry. 2004, 13 (Suppl 1): Barbaresi WJ, Katusic SK, Colligan RC, Pankratz VS, Weaver AL, Weber KJ: How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn. Arch Pediatr Adolesc Med. 2002, 156: 217-224. Biederman J, Faraone SV: Attention-deficit hyperactivity disorder. Lancet. 2005, 366: 237-248. Nigg JT: Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: the state of the field and salient challenges for the coming decade. Biol Psychiatry. 2005, 57: 1424-1435. Sonuga-Barke EJ: Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol Psychiatry. 2005, 57: 1231-1238. Viggiano D, Vallone D, Ruocco LA, Sadile AG: Behavioural, pharmacological, morpho-functional molecular studies reveal a hyperfunctioning mesocortical dopamine system in an animal model of attention deficit and hyperactivity disorder. Neurosci Biobehav Rev. 2003, 27: 683-689. Russell VA, Sagvolden T, Johansen EB: Animal models of attention-deficit hyperactivity disorder. Behav Brain Funct. 2005, 1: 9- Fone KC, Nutt DJ: Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder. Curr Opin Pharmacol. 2005, 5: 87-93. Rothenberger A, Danckaerts M, Dopfner M, Sergeant J, Steinhausen HC: EINAQ – a European educational initiative on Attention-Deficit Hyperactivity Disorder and associated problems. Eur Child Adolesc Psychiatry. 2004, 13 (Suppl 1): I31-I35. Spear LP, Brake SC: Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats. Dev Psychobiol. 1983, 16: 83-109. Teicher MH, Andersen SL, Hostetter JC: Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Brain Res Dev Brain Res. 1995, 89: 167-172. Dawirs RR, Teuchert-Noodt G, Czaniera R: Maturation of the dopamine innervation during postnatal development of the prefrontal cortex in gerbils (Meriones unguiculatus). A quantitative immunocytochemical study. J Hirnforsch. 1993, 34: 281-290. Kalsbeek A, Voorn P, Buijs RM, Pool CW, Uylings HB: Development of the dopaminergic innervation in the prefrontal cortex of the rat. J Comp Neurol. 1988, 269: 58-72. Froimowitz M, Patrick KS, Cody V: Conformational-analysis of methylphenidate and its structural relationship to other dopamine reuptake blockers such as CFT. Pharm Res. 1995, 12: 1430-1434. Gatley SJ, Pan DF, Chen RY, Chaturvedi G, Ding YS: Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci. 1996, 58: L231-L239. Krause KH, Dresel S, Krause J: Wirkmechanismus von Methylphenidat. Kinderärztliche Praxis; Sonderheft "Unaufmerksam und hyperaktiv". Edited by: Voss Hv. 2001, Mainz: Kirchheim-Verlag, 23-27. Wagner GC, Ricaurte GA, Johanson CE, Schuster CR, Seiden LS: Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Neurology. 1980, 30: 547-550. Zaczek R, Battaglia G, Contrera JF, Culp S, Desouza EB: Methylphenidate and pemoline do not cause depletion of rat-brain monoamine markers similar to that observed with methamphetamine. Toxicol Appl Pharmacol. 1989, 100: 227-233. Yuan J, McCann U, Ricaurte G: Methylphenidate and brain dopamine neurotoxicity. Brain Res. 1997, 767: 172-175. Moll GH, Hause S, Ruther E, Rothenberger A, Huether G: Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. J Child Adolesc Psychopharmacol. 2001, 11: 15-24. Andersen SL: Stimulants and the developing brain. Trends Pharmacol Sci. 2005, 26: 237-243. Tennyson VM, Budininkas-Schoenebeck M, Gershon P: Effects of chronic reserpine treatment on development of maturity of the putamen in fetal rabbits. Brain Res Bull. 1982, 9: 651-662. Lauder JM: Neurotransmitters as morphogens. Prog Brain Res. 1988, 73: 365-387. Mattson MP: Neurotransmitters in the regulation of neuronal cytoarchitecture. Brain Res. 1988, 472: 179-212. Teuchert-Noodt G: Neuronal degeneration and reorganization: a mutual principle in pathological and in healthy interactions of limbic and prefrontal circuits. J Neural Transm [Suppl]. 2000, 60: 315-333. Whitaker-Azmitia PM, Murphy R, Azmitia EC: Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. Brain Res. 1990, 528: 155-158. Ferchmin PA, Eterovic VA: Forty minutes of experience increase the weight and RNA content of cerebral cortex in periadolescent rats. Dev Psychobiol. 1986, 19: 511-519. Winterfeld KT, Teuchert-Noodt G, Dawirs RR: Social environment alters both ontogeny of dopamine innervation of the medial prefrontal cortex and maturation of working memory in gerbils (Meriones unguiculatus). J Neurosci Res. 1998, 52: 201-209. Keller A, Bagorda F, Hildebrandt K, Teuchert-Noodt G: Effects of Enriched and of Restricted Rearing on Both Neurogenesis and Synaptogenesis in the Hippocampal Dentate Gyrus of Adult Gerbils (Meriones unguiculatus). Neurology, Psychiatry and Brain Research. 2000, 8: 101-108. Liu D, Diorio J, Day JC, Francis DD, Meaney MJ: Maternal care, hippocampal synaptogenesis and cognitive development in rats. Nat Neurosci. 2000, 3: 799-806. Brake WG, Zhang TY, Diorio J, Meaney MJ, Gratton A: Influence of early postnatal rearing conditions on mesocorticolimbic dopamine and behavioural responses to psychostimulants and stressors in adult rats. Eur J Neurosci. 2004, 19: 1863-1874. Papa M, Diewald L, Carey MP, Esposito FJ, Gironi Carnevale UA, Sadile AG: A rostro-caudal dissociation in the dorsal and ventral striatum of the juvenile SHR suggests an anterior hypo- and a posterior hyperfunctioning mesocorticolimbic system. Behav Brain Res. 2002, 130: 171-179. Grund T: Zum Einfluss von Methylphenidat (MPH; Ritalin®) auf die Reifung von Dopamin in limbo-präfrontalen Arealen von Meriones unguiculatus. Bielefeld; Dissertation. 2005 Grund T, Teuchert-Noodt G, Busche A, Neddens J, Moll GH, Dawirs RR: Oral Methylphenidate During Prepuberty Prevents Pharmacologically-Induced (Preweaning) Suppressive Development of Dopamine Projections into Prefrontal Cortex and Amygdala. 2005, Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Cohen RM: High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder. Am J Psychiatry. 1999, 156: 1209-1215. Cook EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE: Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet. 1995, 56: 993-998. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M: Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry. 1997, 2: 311-313. Castellanos FX, Tannock R: Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci. 2002, 3: 617-628. Fisher SE, Francks C, McCracken JT, McGough JJ, Marlow AJ, MacPhie IL: A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet. 2002, 70: 1183-1196. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ: Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet. 1999, 354: 2132-2133. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K: Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett. 2000, 285: 107-110. Cheon KA, Ryu YH, Kim YK, Namkoong K, Kim CH, Lee JD: Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder. Eur J Nucl Med Mol Imaging. 2003, 30: 306-311. Ernst M, Zametkin AJ, Matochik JA, Jons PH, Cohen RM: DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study. J Neurosci. 1998, 18: 5901-5907. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH: Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology. 2002, 27: 699-711. Marsteller DA, Gerasimov MR, Schiffer WK, Geiger JM, Barnett CR, Borg JS: Acute handling stress modulates methylphenidate-induced catecholamine overflow in the medial prefrontal cortex. Neuropsychopharmacology. 2002, 27: 163-170. Hoffmann IS, Talmaciu RK, Ferro CP, Cubeddu LX: Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals. J Pharmacol Exp Ther. 1988, 245: 761-772. Meador-Woodruff JH, Damask SP, Watson SJ: Differential expression of autoreceptors in the ascending dopamine systems of the human brain. Proc Natl Acad Sci U S A. 1994, 91: 8297-8301. Coulter CL, Happe HK, Bergman DA, Murrin LC: Localization and quantification of the dopamine transporter: comparison of [3H]WIN 35,428 and [125I]RTI-55. Brain Res. 1995, 690: 217-224. Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI: Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci. 1998, 18: 2697-2708. Carboni E, Silvagni A: Dopamine reuptake by norepinephrine neurons: exception or rule?. Crit Rev Neurobiol. 2004, 16: 121-128. Volkow ND, Wang GJ, Fowler JS, Logan J, Gerasimov M, Maynard L: Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci. 2001, 21: U1-U5. Grace AA: Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia. J Neural Transm Gen Sect. 1993, 91: 111-134. Seeman P, Madras B: Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis. Behav Brain Res. 2002, 130: 79-83. Gittelman-Klein R, Klein DF, Katz S, Saraf K, Pollack E: Comparative effects of methylphenidate and thioridazine in hyperkinetic children. I. Clinical results. Arch Gen Psychiatry. 1976, 33: 1217-1231. Weizman A, Weitz R, Szekely GA, Tyano S, Belmaker RH: Combination of neuroleptic and stimulant treatment in attention deficit disorder with hyperactivity. J Am Acad Child Psychiatry. 1984, 23: 295-298. Levy F, Hay DA, McStephen M, Wood C, Waldman I: Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry. 1997, 36: 737-744. Pycock CJ, Carter CJ, Kerwin RW: Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat. J Neurochem. 1980, 34: 91-99. Deutch AY, Clark WA, Roth RH: Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res. 1990, 521: 311-315. Jaskiw GE, Weinberger DR, Crawley JN: Microinjection of apomorphine into the prefrontal cortex of the rat reduces dopamine metabolite concentrations in microdialysate from the caudate nucleus. Biol Psychiatry. 1991, 29: 703-706. Mitchell JB, Gratton A: Partial dopamine depletion of the prefrontal cortex leads to enhanced mesolimbic dopamine release elicited by repeated exposure to naturally reinforcing stimuli. J Neurosci. 1992, 12: 3609-3618. Rosin DL, Clark WA, Goldstein M, Roth RH, Deutch AY: Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems. Neuroscience. 1992, 48: 831-839. Doherty MD, Gratton A: Medial prefrontal cortical D1 receptor modulation of the meso-accumbens dopamine response to stress: an electrochemical study in freely-behaving rats. Brain Res. 1996, 715: 86-97. Busche A, Polascheck D, Lesting J, Neddens J, Teuchert-Noodt G: Developmentally induced imbalance of dopaminergic fibre densities in limbic brain regions of gerbils (Meriones unguiculatus). J Neural Transm. 2004, 111: 451-463. Pitkanen A: Connectivity of the rat amygdaloid complex. The amygdala – A functional analysis. Edited by: Aggleton JP. 2000, Oxford: Oxford University Press, 31-115. Bertolucci-D'Angio M, Serrano A, Driscoll P, Scatton B: Involvement of mesocorticolimbic dopaminergic systems in emotional states. Prog Brain Res. 1990, 85: 405-416. Morgan MA, Romanski LM, LeDoux JE: Extinction of emotional learning: contribution of medial prefrontal cortex. Neurosci Lett. 1993, 163: 109-113. Rosenkranz JA, Grace AA: Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. J Neurosci. 2001, 21: 4090-4103. Davids E, Zhang K, Tarazi FI, Baldessarini RJ: Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev. 2003, 42: 1-21. Russell VA: Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder – the spontaneously hypertensive rat. Neurosci Biobehav Rev. 2003, 27: 671-682. Sagvolden T: Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev. 2000, 24: 31-39. Russell V, de Villiers A, Sagvolden T, Lamm M, Taljaard J: Altered dopaminergic function in the prefrontal cortex, nucleus-accumbens and caudate-putamen of an animal-model of attention-deficit hyperactivity disorder – the spontaneously hypertensive rat. Brain Res. 1995, 676: 343-351. Kirouac GJ, Ganguly PK: Up-regulation of dopamine receptors in the brain of the spontaneously hypertensive rat: an autoradiographic analysis. Neuroscience. 1993, 52: 135-141. Watanabe Y, Fujita M, Ito Y, Okada T, Kusuoka H, Nishimura T: Brain dopamine transporter in spontaneously hypertensive rats. J Nucl Med. 1997, 38: 470-474. Carey MP, Diewald LM, Esposito FJ, Pellicano MP, Gironi Carnevale UA, Sergeant JA: Differential distribution, affinity and plasticity of dopamine D-1 and D-2 receptors in the target sites of the mesolimbic system in an animal model of ADHD. Behav Brain Res. 1998, 94: 173-185. Famularo R, Kinscherff R, Fenton T: Psychiatric diagnoses of maltreated children: preliminary findings. J Am Acad Child Adolesc Psychiatry. 1992, 31: 863-867. Dawirs RR, Teuchert-Noodt G, Czaniera R: Ontogeny of PFC-related behaviours is sensitive to a single non-invasive dose of methamphetamine in neonatal gerbils (Meriones unguiculatus). J Neural Transm. 1996, 103: 1235-1245. Polascheck D: Zum Einfluss epigenetischer Faktoren auf die Reifung aminerger Neurotransmitter im Corpus amygdaloideum und das Verhalten. Eine quantitative Studie an Meriones unguiculatus. Bielefeld; Dissertation. 2004 Dawirs RR, Teuchert-Noodt G, Czaniera R: The postnatal maturation of dopamine innervation in the prefrontal cortex of gerbils (Meriones unguiculatus) is sensitive to an early single dose of methamphetamine. A quantitative immunocytochemical study. J Brain Res. 1994, 35: 195-204. Neddens J, Lesting J, Dawirs RR, Teuchert-Noodt G: An early methamphetamine challenge suppresses the maturation of dopamine fibres in the nucleus accumbens of gerbils: on the significance of rearing conditions. J Neural Transm. 2002, 109: 141-155. Neddens J, Bagorda F, Busche A, Horstmann S, Moll GH, Dawirs RR: Epigenetic factors differentially influence postnatal maturation of serotonin (5-HT) innervation in cerebral cortex of gerbils: interaction of rearing conditions and early methamphetamine challenge. Brain Res Dev Brain Res. 2003, 146: 119-130. Lehmann K, Hundsdorfer B, Hartmann T, Teuchert-Noodt G: The acetylcholine fiber density of the neocortex is altered by isolated rearing and early methamphetamine intoxication in rodents. Exp Neurol. 2004, 189: 131-140. Puumala T, Ruotsalainen S, Jakala P, Koivisto E, Riekkinen P, Sirvio J: Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder. Neurobiol Learn Mem. 1996, 66: 198-211. Arnsten AFT, Dudley AG: Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder. Behav Brain Funct. 2005, 1: 2- Kitazawa S, Hirabayashi S, Kobayashi M: [Memory functions in children with attention deficit/hyperactivity disorder – the effects of methylphenidate on them]. No To Hattatsu. 2004, 36: 31-36. Barkley RA: Attention-Deficit Hyperactivity Disorder. 1990, New York: Guilforld Press Pliszka SR: The neuropsychopharmacology of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005, 57: 1385-1390. Walter J: Kann Ritalin (Methylphenidat) die Schulleistungen von Schülern mit Aufmerksamkeits- und Hyperaktivitätsproblemen verbessern? – Ein Literaturüberblick auf der Basis US-amerikanischer Forschung. Heilpädagogische Forschung. 2001, 27: 106-123. Walter J: Ritalin und Schulleistungen bei HKS: Befunde bei Langfrist- und Kombinationsbehandlungen. Sonderpädagogik. 2001, 31: 191-210. Lehmann K, Butz M, Teuchert-Noodt G: Offer and demand: proliferation and survival of neurons in the dentate gyrus. Eur J Neurosci. 2005, 21: 3205-3216. Rapoport JL, Inoff-Germain G: Responses to methylphenidate in Attention-Deficit/Hyperactivity Disorder and normal children: update 2002. J Atten Disord. 2002, 6 (Suppl 1): S57-S60. Rapoport JL, Buchsbaum MS, Zahn TP, Weingartner H, Ludlow C, Mikkelsen EJ: Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys. Science. 1978, 199: 560-563. Rapoport JL, Buchsbaum MS, Weingartner H, Zahn TP, Ludlow C, Mikkelsen EJ: Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. Arch Gen Psychiatry. 1980, 37: 933-943. Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH: Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci U S A. 1998, 95: 14494-14499. Elliott R, Sahakian BJ, Matthews K, Bannerjea A, Rimmer J, Robbins TW: Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology (Berl). 1997, 131: 196-206. Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW: Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci. 2000, 20: RC65- Moll GH, Heinrich H, Rothenberger A: Methylphenidate and intracortical excitability: opposite effects in healthy subjects and attention-deficit hyperactivity disorder. Acta Psychiatr Scand. 2003, 107: 69-72. Buitelaar JK, Van der Gaag RJ, Swaab-Barneveld H, Kuiper M: Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1995, 34: 1025-1032. Yang PB, Amini B, Swann AC, Dafny N: Strain differences in the behavioral responses of male rats to chronically administered methylphenidate. Brain Res. 2003, 971: 139-152. Yang PB, Swann AC, Dafny N: Chronic pretreatment with methylphenidate induces cross-sensitization with amphetamine. Life Sci. 2003, 73: 2899-2911. Andersen SL, Arvanitogiannis A, Pliakas AM, LeBlanc C, Carlezon WA: Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci. 2002, 5: 13-14. Bolanos CA, Barrot M, Berton O, Wallace-Black D, Nestler EJ: Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry. 2003, 54: 1317-1329. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV: Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics. 1999, 104: E201-E205. Huss M, Lehmkuhl U: Methylphenidate and substance abuse: a review of pharmacology, animal, and clinical studies. J Atten Disord. 2002, 6 (Suppl 1): S65-S71. Brandon CL, Marinelli M, White FJ: Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons. Biol Psychiatry. 2003, 54: 1338-1344. Kuczenski R, Segal DS: Dynamic changes in sensitivity occur during the acute response to cocaine and methylphenidate. Psychopharmacology (Berl). 1999, 147: 96-103. Gerasimov MR, Franceschi M, Volkow ND, Gifford A, Gatley SJ, Marsteller D: Comparison between intraperitoneal and oral methylphenidate administration: A microdialysis and locomotor activity study. J Pharmacol Exp Ther. 2000, 295: 51-57. Kuczenski R, Segal DS: Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci. 2002, 22: 7264-7271. Moll GH, Mehnert C, Wicker M, Bock N, Rothenberger A, Ruther E: Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood. Brain Res Dev Brain Res. 2000, 119: 251-257. Lesting J, Neddens J, Busche A, Teuchert-Noodt G: Hemisphere-specific effects on serotonin but not dopamine innervation in the nucleus accumbens of gerbils caused by isolated rearing and a single early methamphetamine challenge. Brain Res. 2005, 1035: 168-176. Volkow ND, Swanson JM: Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry. 2003, 160: 1909-1918. Swanson JM, Volkow ND: Serum and brain concentrations of methylphenidate: implications for use and abuse. Neurosci Biobehav Rev. 2003, 27: 615-621. Faraj BA, Israili ZH, Perel JM, Jenkins ML, Holtzman SG, Cucinell SA: Metabolism and disposition of methylphenidate-14C: Studies in man and animals. J Pharmacol Exp Ther. 1974, 191: 535-547. Swanson JM, Volkow ND: Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD. Behav Brain Res. 2002, 130: 73-78. Self DW, Nestler EJ: Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Depend. 1998, 51: 49-60. Charach A, Ickowicz A, Schachar R: Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry. 2004, 43: 559-567. Vaidya CJ, Bunge SA, Dudukovic NM, Zalecki CA, Elliott GR, Gabrieli JD: Altered neural substrates of cognitive control in childhood ADHD: evidence from functional magnetic resonance imaging. Am J Psychiatry. 2005, 162: 1605-1613. Pirot S, Glowinski J, Thierry AM: Excitatory responses evoked in prefrontal cortex by mediodorsal thalamic nucleus stimulation: influence of anaesthesia. Eur J Pharmacol. 1995, 285: 45-54. Pirot S, Glowinski J, Thierry AM: Mediodorsal thalamic evoked responses in the rat prefrontal cortex: influence of the mesocortical DA system. Neuroreport. 1996, 7: 1437-1441. Grace AA: Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Brain Res Rev. 2000, 31: 330-341. Rosenkranz JA, Grace AA: Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. J Neurosci. 2002, 22: 324-337.